Quarterly results round-up: COV gets off to flying FY13 start; GETIB's medical systems boasts strong top-line for Q4
This article was originally published in Clinica
Covidien started its new fiscal year with a strong first quarter, beating analysts' expectations with robust top-line growth from its medical devices business.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.